Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| CAL-85-1 | BMS-265246 | 10.0 | 0.0492 | 0.03358 |
| CAL-85-1 | BMS-265246 | 10.0 | -0.0684 | 0.03200 |
| CAL-85-1 | Ulixertinib | 0.001 | 1.1311 | -0.00111 |
| CAL-85-1 | Ulixertinib | 0.001 | 1.2204 | -0.00122 |
| CAL-85-1 | Ulixertinib | 0.001 | 0.9750 | 0.00237 |
| CAL-85-1 | Ulixertinib | 0.003162278 | 1.0124 | -0.00663 |
| CAL-85-1 | Ulixertinib | 0.003162278 | 1.2893 | -0.00300 |
| CAL-85-1 | Ulixertinib | 0.003162278 | 1.2222 | 0.00848 |
| CAL-85-1 | Ulixertinib | 0.01 | 1.1678 | -0.00197 |
| CAL-85-1 | Ulixertinib | 0.01 | 0.9945 | 0.00074 |
| CAL-85-1 | Ulixertinib | 0.01 | -0.0392 | 0.07914 |
| CAL-85-1 | Ulixertinib | 0.031622777 | 1.0405 | -0.00790 |
| CAL-85-1 | Ulixertinib | 0.031622777 | 0.9821 | -0.00151 |
| CAL-85-1 | Ulixertinib | 0.031622777 | -0.1455 | 0.07969 |
| CAL-85-1 | Ulixertinib | 0.1 | 1.0458 | 0.00742 |
| CAL-85-1 | Ulixertinib | 0.1 | 1.0108 | -0.00170 |
| CAL-85-1 | Ulixertinib | 0.1 | 0.6926 | 0.01658 |
| CAL-85-1 | Ulixertinib | 0.316227766 | 0.5892 | 0.01073 |
| CAL-85-1 | Ulixertinib | 0.316227766 | 0.8949 | -0.00023 |
| CAL-85-1 | Ulixertinib | 0.316227766 | 0.6974 | 0.00617 |
| CAL-85-1 | Ulixertinib | 1.0 | 0.7703 | 0.00650 |
| CAL-85-1 | Ulixertinib | 1.0 | 0.8290 | 0.00746 |
| CAL-85-1 | Ulixertinib | 1.0 | 0.8298 | 0.00988 |
| CAL-85-1 | Ulixertinib | 3.16227766 | 0.6853 | 0.01488 |
| CAL-85-1 | Ulixertinib | 3.16227766 | 0.6591 | 0.00187 |